Published in J Immunol Methods on February 13, 2010
Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies. Cells (2012) 1.12
Virtual Global Transplant Laboratory Standard Operating Procedures for Blood Collection, PBMC Isolation, and Storage. Transplant Direct (2016) 1.11
P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1(G93A) amyotrophic lateral sclerosis mice. PeerJ (2017) 0.81
Ultrastructural changes of erythrocytes in whole blood after exposure to prospective in silico-designed anticancer agents: a qualitative case study. Biol Res (2014) 0.78
Restimulation After Cryopreservation and Thawing Preserves the Phenotype and Function of Expanded Baboon Regulatory T Cells. Transplant Direct (2015) 0.75
Non-immunogenicity of overlapping gag peptides pulsed on autologous cells after vaccination of HIV infected individuals. PLoS One (2013) 0.75
Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy. Sci Rep (2017) 0.75
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med (2006) 10.34
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol (2006) 6.30
Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol (2002) 4.63
Adaptation of HIV-1 to human leukocyte antigen class I. Nature (2009) 4.24
Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med (2005) 3.68
Exclusion of a luminous red giant as a companion star to the progenitor of supernova SN 2011fe. Nature (2011) 3.62
Supernova SN 2011fe from an exploding carbon-oxygen white dwarf star. Nature (2011) 3.29
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol (2011) 3.25
Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain (2007) 3.07
Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry (2002) 2.86
High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS (2007) 2.73
The type Ia supernova SNLS-03D3bb from a super-Chandrasekhar-mass white dwarf star. Nature (2006) 2.72
Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS (2008) 2.65
Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med (2010) 2.43
Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine (2005) 1.94
Temporal and reciprocal relationship between IADL/ADL disability and depressive symptoms in late life. J Gerontol B Psychol Sci Soc Sci (2002) 1.82
Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol (2003) 1.67
Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain (2011) 1.65
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood (2012) 1.60
Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J Infect Dis (2005) 1.58
Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med (2011) 1.56
First introduction of highly pathogenic H5N1 avian influenza A viruses in wild and domestic birds in Denmark, Northern Europe. Virol J (2007) 1.53
Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Med (2007) 1.53
International perspectives, progress, and future challenges of paediatric HIV infection. Lancet (2007) 1.52
HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS (2010) 1.45
The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol J (2008) 1.45
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE. Vaccine (2009) 1.36
HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. J Virol (2011) 1.31
Superluminous supernovae at redshifts of 2.05 and 3.90. Nature (2012) 1.30
'Unleashed' natural killers hinder HIV. Nat Genet (2007) 1.27
Statistical resolution of ambiguous HLA typing data. PLoS Comput Biol (2008) 1.25
The relationship of attachment style to depression, catastrophizing and health care utilization in patients with chronic pain. Pain (2003) 1.24
Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations. PLoS One (2011) 1.24
Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption. Antivir Ther (2005) 1.22
Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res (2005) 1.21
Structural genomics of pathogenic protozoa: an overview. Methods Mol Biol (2008) 1.20
Pain limits the effectiveness of collaborative care for depression. Am J Geriatr Psychiatry (2007) 1.15
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes. AIDS (2009) 1.12
HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides. Immunogenetics (2010) 1.11
Multiple human papilloma virus types in cervical infections: competition or synergy? APMIS (2010) 1.11
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10
Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost. J Gen Virol (2003) 1.07
High frequency of multiple HPV types in cervical specimens from Danish women. APMIS (2009) 1.05
High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis (2011) 1.05
Response styles among patients with minor depression and dysthymia in primary care. J Abnorm Psychol (2002) 1.02
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa. Clin Infect Dis (2009) 1.02
Type IIn supernovae at redshift z approximately 2 from archival data. Nature (2009) 1.01
Feasibility and effectiveness of an automated bilingual text message intervention for weight loss: pilot study. JMIR Res Protoc (2013) 1.01
HIV control through a single nucleotide on the HLA-B locus. J Virol (2012) 1.00
The microbial detection array combined with random Phi29-amplification used as a diagnostic tool for virus detection in clinical samples. PLoS One (2011) 1.00
Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate. J Virol (2010) 1.00
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer. Mol Cancer Ther (2009) 0.99
Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101. J Virol (2010) 0.99
Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. J Gen Virol (2003) 0.98
Nef-specific CD8+ T cell responses contribute to HIV-1 immune control. PLoS One (2013) 0.98
Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllers. J Acquir Immune Defic Syndr (2011) 0.97
Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain. J Adolesc Health (2012) 0.96
Placebos and treatment of pain. Pain Med (2004) 0.95
Predictors of nonresponse to treatment in primary care patients with dysthymia. Gen Hosp Psychiatry (2002) 0.95
A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice. PLoS One (2009) 0.95
Preventing medication errors with smart infusion technology. Am J Health Syst Pharm (2004) 0.95
Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy. BJU Int (2012) 0.94
Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells. J Virol (2012) 0.93
Genetic and biological characterisation of an avian-like H1N2 swine influenza virus generated by reassortment of circulating avian-like H1N1 and H3N2 subtypes in Denmark. Virol J (2013) 0.93
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. PLoS One (2013) 0.91
A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape. Retrovirology (2015) 0.90
APS position statement on the use of placebos in pain management. J Pain (2005) 0.90
Longitudinal analysis of CD8 T-cell responses to HIV and hepatitis C virus in a cohort of co-infected haemophiliacs. AIDS (2005) 0.90
What is the appropriate oxygen tension for in vitro culture? Mol Hum Reprod (2006) 0.89
Trends in the prescription of opioids for adolescents with non-cancer pain. Gen Hosp Psychiatry (2011) 0.89
Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection. AIDS (2011) 0.89
Routine genotyping of human papillomavirus samples in Denmark. APMIS (2003) 0.89
Factors influencing T cell activation and programmed death 1 expression in HIV-infected children. AIDS Res Hum Retroviruses (2011) 0.88
Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod (2006) 0.87
A plasmid selection system in Lactococcus lactis and its use for gene expression in L. lactis and human kidney fibroblasts. Appl Environ Microbiol (2002) 0.87
The relationship between health risks and health and productivity costs among employees at Pepsi Bottling Group. J Occup Environ Med (2010) 0.87
An intravenous medication safety system: preventing high-risk medication errors at the point of care. J Nurs Adm (2004) 0.86
Correlates of remission in primary care patients treated for minor depression. Gen Hosp Psychiatry (2002) 0.86
Identification of cowpox infection in a 13-year-old Danish boy. Acta Derm Venereol (2008) 0.86
Psychoactive substances and the political ecology of mental distress. Harm Reduct J (2012) 0.86
HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01. J Virol (2013) 0.85
A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection. Vaccine (2013) 0.85
Adjuvanted HLA-supertype restricted subdominant peptides induce new T-cell immunity during untreated HIV-1-infection. Clin Immunol (2012) 0.84
Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau. AIDS Res Hum Retroviruses (2013) 0.83
Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. Hum Vaccin Immunother (2015) 0.83
Genetic subspecies diversity of the chimpanzee CD4 virus-receptor gene. Genomics (2008) 0.83
Tick-borne encephalitis virus, Zealand, Denmark, 2011. Emerg Infect Dis (2013) 0.83
HIV-specific ADCC improves after antiretroviral therapy and correlates with normalization of the NK cell phenotype. J Acquir Immune Defic Syndr (2015) 0.82
Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases. Immunology (2011) 0.82
Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120. Genet Vaccines Ther (2007) 0.82
Robot-assisted partial nephrectomy: a comparison of the transperitoneal and retroperitoneal approaches. J Endourol (2013) 0.81
Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope. Cancer Immunol Immunother (2007) 0.81
Assessment of HIV-1 patient recruitability in the Republic of Guinea-Bissau using African versus North American hematology and biochemistry reference intervals. Clin Vaccine Immunol (2012) 0.81
Oxygen cost of exercise is increased in heart failure after accounting for recovery costs. Chest (2003) 0.81
HIV-1-infected individuals in antiretroviral therapy react specifically with polyfunctional T-cell responses to Gag p24. J Acquir Immune Defic Syndr (2013) 0.81
Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades. Influenza Other Respir Viruses (2010) 0.81
Renal cell carcinoma with retro-aortic renal vein thrombus: a case series. BJU Int (2009) 0.81